ReviewOncoTargets and therapy2022

Evaluating the Therapeutic Potential of Idecabtagene Vicleucel in the Treatment of Multiple Myeloma: Evidence to Date.

Hashim Mann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.